AR084537A1 - AMBROXOL WATER SOLUTION - Google Patents

AMBROXOL WATER SOLUTION

Info

Publication number
AR084537A1
AR084537A1 ARP110104880A ARP110104880A AR084537A1 AR 084537 A1 AR084537 A1 AR 084537A1 AR P110104880 A ARP110104880 A AR P110104880A AR P110104880 A ARP110104880 A AR P110104880A AR 084537 A1 AR084537 A1 AR 084537A1
Authority
AR
Argentina
Prior art keywords
ambroxol
water solution
content
aqueous solution
polyols
Prior art date
Application number
ARP110104880A
Other languages
Spanish (es)
Inventor
Gianluigi Passetti
Original Assignee
Advance Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45094329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR084537(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advance Holdings Ltd filed Critical Advance Holdings Ltd
Publication of AR084537A1 publication Critical patent/AR084537A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)

Abstract

Una solución acuosa que comprende una sal de adición de ácido de ambroxol, en la que el contenido de ambroxol está comprendido entre 0,1% y 7% (p/v), el contenido total de polialcoholes seleccionados de entre polioles y polialquilenglicoles es de por lo menos 20% (p/v), el contenido de alcoholes es inferior a 1% (p/v) y dicha solución acuosa está exenta de ácido benzoico y/o sus sales con bases orgánicas o inorgánicas.An aqueous solution comprising an ambroxol acid addition salt, in which the ambroxol content is comprised between 0.1% and 7% (w / v), the total content of polyols selected from polyols and polyalkylene glycols is at least 20% (w / v), the alcohol content is less than 1% (w / v) and said aqueous solution is free of benzoic acid and / or its salts with organic or inorganic bases.

ARP110104880A 2010-12-23 2011-12-22 AMBROXOL WATER SOLUTION AR084537A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10196711 2010-12-23

Publications (1)

Publication Number Publication Date
AR084537A1 true AR084537A1 (en) 2013-05-22

Family

ID=45094329

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110104880A AR084537A1 (en) 2010-12-23 2011-12-22 AMBROXOL WATER SOLUTION

Country Status (13)

Country Link
EP (1) EP2654719A1 (en)
JP (1) JP2014503542A (en)
KR (1) KR20130140042A (en)
CN (1) CN103269685A (en)
AR (1) AR084537A1 (en)
AU (1) AU2011347257A1 (en)
BR (1) BR112013012815A2 (en)
CA (1) CA2817453A1 (en)
CL (1) CL2013001297A1 (en)
EA (1) EA201300535A1 (en)
MX (1) MX2013005500A (en)
NZ (1) NZ609742A (en)
WO (1) WO2012085185A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102083621B1 (en) * 2013-06-13 2020-03-02 한미약품 주식회사 Oral liquid formulation having improved stability comprising ambroxol and levodropropizine
CN103462942B (en) * 2013-08-20 2016-12-28 湖南赛隆药业有限公司 A kind of suction ambroxol hydrochloride solution
CN104316482A (en) * 2014-08-15 2015-01-28 河北菲尼斯生物技术有限公司 A quality control method for ambroxol hydrochloride particles
CN105287367B (en) * 2015-10-13 2018-07-10 华润三九（南昌）药业有限公司 A kind of oral liquid of ambroxol hydrochloride and preparation method and application
CN109060473B (en) * 2018-07-27 2021-03-05 商洛学院 Preparation method of ambroxol hydrochloride impurity reference substance
CN113995721A (en) * 2020-07-27 2022-02-01 德国吉麦医疗技术有限公司 Ambroxol hydrochloride oral spray solution and preparation method thereof
CN112168783A (en) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 Oral medicine spray for respiratory system and preparation method thereof
CN112168782A (en) * 2020-10-26 2021-01-05 山东裕欣药业有限公司 Preparation method of respiratory system medicine oral spray
CN114129510A (en) * 2021-12-03 2022-03-04 聊城大学 Compound sulfanilamide injection and preparation method thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
JP2000007561A (en) * 1998-06-18 2000-01-11 Nissho Corp Ambroxol hydrochloride aqueous solution preparation
DE19933148A1 (en) 1999-07-20 2001-01-25 Boehringer Ingelheim Int Lozenge containing ambroxol
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
US20030171391A1 (en) 2002-01-25 2003-09-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of chronic pain
DE10240802A1 (en) 2002-08-30 2004-04-15 W.L. Gore & Associates Gmbh IR reflective material
DE10332486A1 (en) 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of acute pain
AU2004270266B2 (en) * 2003-09-09 2011-02-10 3M Innovative Properties Company Concentrated antimicrobial compositions and methods
US20050075403A1 (en) 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032463A1 (en) 2003-12-16 2005-06-17 Advance Holdings Ltd AQUEOUS CONCENTRATED AMBROXOL SOLUTION
DE102004021992A1 (en) 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topical preparation containing ambroxol
CN101961307B (en) * 2010-09-14 2012-07-25 武汉人福药业有限责任公司 Oral liquid for treating respiratory disease and preparation method thereof

Also Published As

Publication number Publication date
CA2817453A1 (en) 2012-06-28
WO2012085185A1 (en) 2012-06-28
EP2654719A1 (en) 2013-10-30
CL2013001297A1 (en) 2013-10-11
EA201300535A1 (en) 2013-08-30
CN103269685A (en) 2013-08-28
MX2013005500A (en) 2013-09-26
BR112013012815A2 (en) 2016-09-13
AU2011347257A1 (en) 2013-05-23
JP2014503542A (en) 2014-02-13
NZ609742A (en) 2015-01-30
KR20130140042A (en) 2013-12-23

Similar Documents

Publication Publication Date Title
AR084537A1 (en) AMBROXOL WATER SOLUTION
ES2504175T3 (en) Acid and liquid hard surface cleaning composition
BRPI1014319A2 (en) system to minimize circulation loss associated with the operation of an underground reservoir, and, computer-implemented method.
ES2488407T3 (en) Pharmaceutical preparation containing lipase of bacterial origin
CL2013001589A1 (en) Use of an emulsion comprising 0.08% by weight or less of antimicrobial essential oil, acacia gum and water to provide an antimicrobial effect in an aqueous composition; process to improve the antimicrobial effect of an antimicrobial essential oil; and aqueous composition comprising an antimicrobial emulsion.
BRPI0909089A2 (en) refinement and recommendations for research powered by social networking
CR20150559A (en) PROCESSING SYSTEM FOR MULTIPLE BATCHES FOR THE PREPARATION OF A SOLUTION OF ADEQUATE HYDROGEN CARBONATE, FOR THE REMINERALIZATION OF DESALINIZED WATER AND WHITE WATER OF NATURAL ORIGIN
CL2013000163A1 (en) Process for the preparation of calcium carbonate material comprising providing at least one material containing calcium carbonate, providing at least one salt of a c5-c28 fatty acid, treating the material by contacting said fatty acid and obtaining said material superficially treated; calcium carbonate material; and its use in the control of organic material in an aqueous medium.
ES2543957T3 (en) New pharmaceutical composition for the treatment of fungal infections
CL2012001443A1 (en) Method and system to reduce and optimize the proportion of fouling in a unit, comprising estimating a concentration and determining the potential of fouling contained in a fluid, determining the impact of the antifouling chemical on the potential of fouling, comparing the acceptable potential with the concentration of incrustations in subsequent operations and regulate the entry of said chemical
CL2008001605A1 (en) An intranasal dosage formulation comprising asenapine or a pharmaceutically acceptable salt and a liquid carrier containing water and a polyol, useful for the treatment of schizophrenia.
BR112012028706A2 (en) method for decreasing the pH of an aqueous solution using urea sulfate in the presence of a corrosion inhibitor
CO6382164A2 (en) WATER SOLUTION FOR THE PRESERVATION OF FABRICS AND ORGANS
ES2508165T3 (en) Lactoferrin and white matter
AR089486A1 (en) PHARMACEUTICAL PREPARATION INCLUDING b-CYCLODEXTRINE REPLACED
CL2012001409A1 (en) Method to disinfect drinker systems online based on an alkaline aqueous solution comprising at least 50,000 ppm of active bromine.
SV2009003287A (en) AGENTS TO COMBAT PARASITES IN ANIMALS
ES2494140T3 (en) Boron compound suspension
CL2015000957A1 (en) Methods to reduce encrustant formation
CL2011000621A1 (en) Agent containing at least one acylcyclohexanedionecarboxylic acid and / or its salts in combination with at least one ester of acylcyclohexanedionecarboxylic acid and its use to improve the development of grasses.
CR8537A (en) HM74 Oxidecahydronaphthalene Modulators
CL2014000510A1 (en) Process for water remineralization, which comprises a) providing feedwater, b) providing an aqueous solution of calcium carbonate which contains dissolved calcium carbonate and its reaction species, and c) combining the feedwater from step a) and the solution of step b); and use of the calcium carbonate solution.
CL2013003727A1 (en) Method for the treatment of lice in fish comprising the contacting of water, housing said fish, with particulate lime (calcium oxide and / or calcium hydroxide); composition comprising particulate lime and its uses.
CL2009001888A1 (en) Nutritional formula that has a pH in the liquid state of 4.8 to 5.2, comprising 1 to 1.2% of lactic acid and between 0.9 to 1.4% of a lactic acid salt, selected from lactate of sodium, potassium or calcium.
CL2012001761A1 (en) A method for the reduction and / or control of scale in a system, comprising the addition of a trimethylglycine composition to the scale reduction and accumulation system.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal